title: Do women with ovaries of polycystic morphology without any other features of PCOS benefit from short-term metformin co-treatment during IVF? A double-blind, placebo-controlled, randomized trial.
abstract: BACKGROUND
  Women with ovaries of polycystic morphology (PCO), without any other features of polycystic ovary syndrome (PCOS), respond similarly to women with PCOS when stimulated with exogenous gonadotrophins, and both groups share various endocrinological disturbances underlying their pathology. In women with PCOS, metformin co-treatment during IVF has been shown to increase pregnancy rates and reduce the risk of ovarian hyperstimulation syndrome (OHSS). The aim of this study was to investigate whether metformin co-treatment before and during IVF can also increase the live birth rate (LBR) and lower severe OHSS rates for women with PCO, but no other manifestations of PCOS.
  
  
  METHODS
  This study was a double-blind, multi-centre, randomized, placebo-controlled trial. The study population included 134 women with ovulatory PCO (and no evidence of clinical or biochemical hyperandrogenism) undergoing IVF treatment at three tertiary referral IVF units. The primary outcome was LBR.
  
  
  RESULTS
  In total, 134 women were randomized, 69 to metformin and 65 to placebo. There were no statistically significant differences between the two groups in baseline characteristics. With regard to IVF outcome, no significant improvements were found in the metformin group when compared with the placebo group. In particular, there was no difference between the groups in rates of live birth [metformin n = 27 (39.1%), placebo n = 30 (46.2), (95% confidence interval 0.38, 1.49, odds ratio = 0.75)], clinical pregnancy [metformin n = 29 (42.0%), placebo n = 33 (50.8%)] or severe OHSS [metformin n = 6 (8.7%), placebo n = 5 (7.7%)].
  
  
  CONCLUSIONS
  There appears to be no benefit in metformin co-treatment before and during IVF in women with PCO without any other features of PCOS. Clinical Trials.gov: NCT01046032.
authors: Department of Gynaecology, Royal Berkshire Hospital, Reading RG1 5AN, UK. alex.swanton@royalberkshire.nhs.uk
authors: Alexander
authors: A
authors: Swanton
authors: Antony
authors: A
authors: Lighten
authors: Ingrid
authors: I
authors: Granne
authors: Enda
authors: E
authors: McVeigh
authors: Stuart
authors: S
authors: Lavery
authors: Geoff
authors: G
authors: Trew
authors: Alon
authors: A
authors: Talmor
authors: Nick
authors: N
authors: Raine-Fenning
authors: Kannamannadiar
authors: K
authors: Jayaprakasan
authors: Tim
authors: T
authors: Child